Prostate Cancer : Episode 12

Video

Episode 12 - Specialty Pharmacy's Role in CRPC

While discussing channel management in urology, Jeffrey D. Dunn, PharmD, MBA, introduces specialty pharmacy’s role.

Moderator Raoul S. Concepcion, MD, explains that the concept of pharmacy benefit is relatively new in the field of urology.

Dr Dunn and Michael Kolodziej, MD, explain their concerns about treatment expenses, care management, and the challenge for clinicians to select the specialty pharmacy of their choice.

Additionally, David Quinn, MD, explains why the administration of parenteral drugs through infusion centers has become a concern to clinicians.


Related Videos
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Elizabeth Grush, MBA
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Erin Weber, MS
Kenny Cole, MD
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Joseph Saseen, PharmD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Andrew Evens, DO
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo